| | | | | | | |
 | GILEAD SCIENCES, INC. | 0.89% | -1.23% | -14.12% | -9.79% | -8.06% | 77 529 |
| VERTEX PHARMACEUTICALS | 1.96% | -0.60% | 30.84% | 42.09% | 58.01% | 72 069 |
| REGENERON PHARMACEUTICALS, INC. | 0.72% | -2.68% | -5.72% | 3.62% | 88.08% | 63 692 |
 | WUXI APPTEC CO., LTD. | -1.14% | -0.64% | -13.31% | -38.81% | 165.41% | 45 031 |
| BIONTECH SE | 5.63% | 12.71% | -38.91% | -29.69% | --.--% | 36 234 |
 | GENMAB A/S | 2.79% | 6.20% | -10.23% | -8.56% | 95.29% | 21 148 |
 | ARGENX SE | 1.45% | 5.15% | 15.03% | 43.30% | 187.17% | 20 418 |
| BEIGENE, LTD. | 3.15% | 3.62% | -38.38% | -52.25% | 31.42% | 16 726 |
| NEUROCRINE BIOSCIENCES, INC. | 1.82% | 0.08% | 16.53% | 1.84% | 16.49% | 9 317 |
| LEGEND BIOTECH CORPORATION | 1.53% | 7.63% | 19.80% | 33.65% | --.--% | 8 483 |
| EXELIXIS, INC. | 3.60% | -2.39% | 18.00% | 15.72% | 0.33% | 6 678 |
| SAREPTA THERAPEUTICS, INC. | 1.00% | 4.37% | -15.92% | -3.27% | -51.65% | 6 559 |
| HALOZYME THERAPEUTICS, INC. | 1.09% | -1.35% | 10.62% | -4.06% | 153.16% | 6 062 |
| INTRA-CELLULAR THERAPIES, INC. | -3.35% | -0.19% | 5.41% | 29.84% | 293.23% | 5 384 |
| ASCENDIS PHARMA A/S | -0.39% | 1.63% | -31.17% | -31.15% | -22.12% | 5 188 |
| | | | | | | |
| | Gemiddelde | 1.38% | 2.15% | -3.43% | -0.50% | 77.44% | |
| | Gewogen gemiddelde per kap. | 1.49% | 1.24% | -3.81% | -0.32% | 70.79% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (België)
